Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Applied Molecular Transport Inc (AMTI)

Applied Molecular Transport Inc (AMTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Applied Molecular Transport Inc 450 East Jamie Court South San Francisco CA 94080 USA

www.appliedmt.com P: 650-392-0420

Description:

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. It design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic and other diseases. The company's lead product candidate consist AMT-101, which is in clinical stage. Applied Molecular Transport Inc. is based in Calif.

Key Statistics

Overview:

Market Capitalization, $K 10,872
Enterprise Value, $K -50,278
Shares Outstanding, K 41,337
Annual Sales, $ 0 K
Annual Net Income, $ -126,330 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,940 K
EBIT, $ -76,530 K
EBITDA, $ -73,400 K
60-Month Beta 2.28
% of Insider Shareholders 15.90%
% of Institutional Shareholders 41.79%
Float, K 34,764
% Float 84.10%
Short Volume Ratio 0.10

Growth:

1-Year Return -39.54%
3-Year Return -99.15%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.17 on 11/09/23
Latest Earnings Date 11/13/23
Earnings Per Share ttm -1.90
EPS Growth vs. Prev Qtr 61.36%
EPS Growth vs. Prev Year 73.85%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AMTI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -223.46%
Return-on-Assets % -126.91%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.64
Book Value/Share 0.41
Interest Coverage -2.38
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar